Blindness caused by diabetes--Massachusetts, 1987-1994
- PMID: 8927019
Blindness caused by diabetes--Massachusetts, 1987-1994
Abstract
Diabetes, the leading cause of new blindness among U.S. adults aged 20-74 years, accounts for approximately 8% of cases of legal blindness and 12% of all new cases of blindness in the United States each year. One of the national health objectives for the year 2000 is to decrease by 50% the incidence of blindness caused by diabetes (objective 17.10). However, surveillance for blindness among persons with diabetes has not been conducted nationally, and national prevalence estimates of blindness caused by diabetes have been based on state data from the register of the Massachusetts Commission for the Blind (MCB). To characterize recent trends, data on legal blindness caused by diabetes among adults with diabetes in Massachusetts were examined for 1987-1994. This report summarizes the results of that analysis, which indicate that in Massachusetts, the overall incidence and prevalence of legal blindness caused by diabetes did not decrease, despite the availability of methods to prevent vision loss.
Similar articles
-
Prevalence of visual impairment and selected eye diseases among persons aged >/=50 years with and without diabetes--United States, 2002.MMWR Morb Mortal Wkly Rep. 2004 Nov 19;53(45):1069-71. MMWR Morb Mortal Wkly Rep. 2004. PMID: 15549022
-
Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998-2003.Isr Med Assoc J. 2006 Dec;8(12):880-1. Isr Med Assoc J. 2006. PMID: 17214111
-
Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.Acta Ophthalmol Scand Suppl. 1997;(223):1-76. Acta Ophthalmol Scand Suppl. 1997. PMID: 9559048
-
Public health focus: prevention of blindness associated with diabetic retinopathy.MMWR Morb Mortal Wkly Rep. 1993 Mar 19;42(10):191-5. MMWR Morb Mortal Wkly Rep. 1993. PMID: 8446094
-
[Epidemiology of diabetes-induced blindness -- a review].Klin Monbl Augenheilkd. 2002 Nov;219(11):777-84. doi: 10.1055/s-2002-36318. Klin Monbl Augenheilkd. 2002. PMID: 12494367 Review. German.
Cited by
-
Endothelin receptor-A antagonist attenuates retinal vascular and neuroretinal pathology in diabetic mice.Invest Ophthalmol Vis Sci. 2014 Apr 17;55(4):2516-25. doi: 10.1167/iovs.13-13676. Invest Ophthalmol Vis Sci. 2014. PMID: 24644048 Free PMC article.
-
Results of a community-based screening programme for diabetic retinopathy and childhood blindness in district Hyderabad, Pakistan.BMJ Open Ophthalmol. 2017 Dec 15;2(1):e000099. doi: 10.1136/bmjophth-2017-000099. eCollection 2017. BMJ Open Ophthalmol. 2017. PMID: 29354723 Free PMC article.
-
Design and Development of a Mobile-Based Self-Care Application for Patients with Type 2 Diabetes.J Diabetes Sci Technol. 2022 Jul;16(4):1008-1015. doi: 10.1177/19322968211007124. Epub 2021 Apr 10. J Diabetes Sci Technol. 2022. PMID: 33840235 Free PMC article.
-
Mechanisms Underlying Early-Stage Changes in Visual Performance and Retina Function After Experimental Induction of Sustained Dyslipidemia.Neurochem Res. 2018 Aug;43(8):1500-1510. doi: 10.1007/s11064-018-2563-2. Epub 2018 Jun 2. Neurochem Res. 2018. PMID: 29860619 Free PMC article.
-
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy.Int J Mol Sci. 2016 Sep 7;17(9):1498. doi: 10.3390/ijms17091498. Int J Mol Sci. 2016. PMID: 27618014 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical